Your guide to the RSV vaccine for older adults
Updated 10 July 2025
Applies to England
© Crown copyright 2025
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at /government/publications/respiratory-syncytial-virus-rsv-vaccination-for-older-adults/your-guide-to-the-rsv-vaccine-for-older-adults
From 1 September 2024, those who turn 75 and those aged 75 to 79 will be eligible for a free vaccine to protect them from respiratory syncytial virus (RSV).
RSV is an infectious disease of the airways and lungs. RSV infection often causes symptoms similar to a cold, including:
- cough
- sore throat
- sneezing
- a runny or blocked nose
It can also make you become wheezy or short of breath and lead to pneumonia and other life-threatening conditions. There is no specific treatment, and most infections will get better by themselves. Every year thousands of older adults need hospital care for RSV, and some of them will die. RSV can be more severe in people with medical conditions such as heart or lung disease or a weakened immune system.
RSV infection is common in young children but is most serious for small babies and for older people.
How RSV is spread
RSV infections can occur all year round but cases peak every winter.
RSV can spread through coughs and sneezes. You can help to prevent the spread of the virus by covering your mouth and nose when you cough or sneeze (ideally with a tissue, or else into the bend of your elbow), and you can wash your hands frequently to reduce the risk of picking up the virus. Even with these measures it can be difficult to avoid RSV infection.
The best way to protect yourself is to have the vaccine.
How the RSV vaccine works
Almost all older adults will have had several RSV infections during their life. A single dose of vaccine will help to boost protection as you reach an age group at highest risk of serious RSV infection. Unlike the flu vaccine you do not need to have the RSV vaccine every year.
Eligibility for the RSV vaccination
Everyone turning 75 years old on or after the 1 September 2024 will be offered a single dose of RSV vaccine. This is because older adults are more at risk of serious complications from RSV. The vaccine will also be offered to those who are already aged 75 to 79 years on 1 September 2024 as part of a catch up programme. You can still get the vaccine up to the day before you turn 80. Anyone who was 79 when the catch-up programme started can have the vaccine up to 31 August 2025 even if they have already turned 80.
If you are not yet 75 the NHS will invite you for vaccination once you turn 75.
Having the RSV vaccine at the same time as other vaccines
COVID-19, Shingles and pneumococcal vaccines
You may be offered your COVID-19, shingles or pneumococcal vaccine at the same time as the RSV vaccine, it is safe to do so and reduces the number of appointments you will need to get protected from these diseases.
Flu vaccine
RSV isn’t normally arranged to be given at the same appointment as your flu vaccine.
In certain clinical circumstances, your doctor or nurse can safely offer them at the same time.
Those who should not have the RSV vaccine
Almost everybody can have the vaccine, but tell the doctor or nurse if you have ever had a serious allergy to a vaccine, or any of the ingredients.
You can read the patient information leaflet for the RSV vaccine called .
If you have a minor illness such as a cold you can receive the vaccine, but if you are very unwell or have a fever, the doctor or nurse may advise you to wait until you are better.
The protection offered by the RSV vaccine
The vaccine has been shown to reduce the chance of you suffering from RSV disease. As with all medicines, no vaccine is completely effective and some people may still get RSV despite having a vaccination. If you do get RSV, it should be less severe.
How long the RSV vaccine will protect you for
In the clinical studies, RSV vaccine provided good protection for at least 2 years and is expected to last longer.
Side effects from the RSV vaccine
You may get some soreness, redness or swelling at the site of the injection for a day or two after the vaccination.
Over 12 million doses have been given to older adults in the USA and UK. A rare, but serious, nervous system condition known as Guillain-Barré syndrome that leads to weakness was reported, around 1 case for every 40,000 to 100,000 doses given, in the 6 weeks after vaccination. The same condition also occurs after a number of common infections and some vaccines. If you have symptoms such as tingling, numbness, weakness, sharp pain or pins and needles in your hands, feet, arms or legs, you should seek immediate medical attention. Overall it is safer for you to have the vaccine than to risk having a potentially serious RSV infection.
You can report suspected side effects to the Medicines and Healthcare products Regulatory Agency (MHRA):
- on the
- by calling the free phone line: 0800 731 6789 (9am to 5pm, Monday to Friday)
- by downloading the Yellow Card App on or
Translated versions of this information
Translated versions of this leaflet are available to download or order as a physical copy from the Health Publications website in the following languages:
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , and .
Further information
If you have further questions, speak to your practice nurse, GP or health team.
Read the .